1.World Obesity Federation, World Obesity Atlas 2023.https://data.worldobesity.org/publications/?cat=19;
2.Bakaloudi DR et al, 2022. Impact of the first COVID-19 lockdown on body weight: A combined systematic review and a meta-analysis. Clin Nutr; 41(12): 3046–3054.3.Yang S et al, 2020. Obesity and activity patterns before and during COVID-19 lockdown among youths in China. Clin Obes; 10(6): e12416.4.Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. NEJM. June 2022.5.Capozzi ME, DiMarchi RD, Tschöp MH, et al. Targeting the incretin/glucagon system with triagonists to treat diabetes. Endocr Rev,2018, 39(5): 719-738.6.Tan Tricia M-M,Co-agonist therapeutics come of age for obesity.[J] .Nat Rev Endocrinol, 2023, 19: 66-67. 责编:苏志强